These findings will extend our understanding of abnormal liver lipid metabolism under starvation stress and clarify the intervention effect of cd36 as a target, which may provide new strategies for the treatment of NAFLD. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.